does retatrutide help with fatty liver study Researchers report promising results retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic liver disease (MASLD retatrutide nonalcoholic steatohepatitis nash trial

mean difference = 1.31% [95% CI, 2.99 to 0.37]

Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned

Tirzepatide: Dual-Action Weight Loss Therapy Tirzepatide, found in Zepbound, works on two hormone receptors: GLP-1 (appetite and satiety) GIP (glucose-dependent insulinotropic polypeptide), which plays a role in insulin sensitivity and fat metabolism This dual-action approach often leads to: Greater appetite suppression Enhanced effects on blood sugar regulation Higher average weight-loss outcomes in many patients Because tirzepatide influences more than one metabolic pathway, it may be particularly beneficial for individuals with insulin resistance or metabolic syndrome

The GLP-1 activity does not work alone